Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Argenx Se (ARGX) Research & Development (2016 - 2025)

Historic Research & Development for Argenx Se (ARGX) over the last 10 years, with Q3 2025 value amounting to -$355.7 million.

  • Argenx Se's Research & Development fell 5073.79% to -$355.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.3 billion, marking a year-over-year decrease of 2993.02%. This contributed to the annual value of $983.4 million for FY2024, which is 1441.91% up from last year.
  • Latest data reveals that Argenx Se reported Research & Development of -$355.7 million as of Q3 2025, which was down 5073.79% from -$327.7 million recorded in Q2 2025.
  • In the past 5 years, Argenx Se's Research & Development ranged from a high of -$122.3 million in Q1 2021 and a low of -$355.7 million during Q3 2025
  • For the 5-year period, Argenx Se's Research & Development averaged around -$214.7 million, with its median value being -$195.5 million (2023).
  • Data for Argenx Se's Research & Development shows a peak YoY increase of 4838.77% (in 2021) and a maximum YoY decrease of 12452.27% (in 2021) over the last 5 years.
  • Argenx Se's Research & Development (Quarter) stood at -$167.2 million in 2021, then rose by 11.59% to -$147.8 million in 2022, then crashed by 107.29% to -$306.4 million in 2023, then increased by 2.98% to -$297.2 million in 2024, then fell by 19.66% to -$355.7 million in 2025.
  • Its Research & Development stands at -$355.7 million for Q3 2025, versus -$327.7 million for Q2 2025 and -$309.1 million for Q1 2025.